Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,024,000 | 985,000 | 4,566,000 | 2,933,000 | 1,147,000 |
| Depreciation Amortization | 1,321,000 | 640,000 | 2,103,000 | 1,575,000 | 1,050,000 |
| Income taxes - deferred | -524,000 | -303,000 | -1,552,000 | -1,214,000 | -944,000 |
| Accounts receivable | 549,000 | 635,000 | -406,000 | -125,000 | 247,000 |
| Accounts payable and accrued liabilities | -275,000 | -272,000 | 226,000 | -38,000 | -104,000 |
| Other Working Capital | -211,000 | -542,000 | -1,763,000 | -1,880,000 | -1,763,000 |
| Other Operating Activity | 1,198,000 | 601,000 | 5,898,000 | 5,254,000 | 4,009,000 |
| Operating Cash Flow | $4,082,000 | $1,744,000 | $9,072,000 | $6,505,000 | $3,642,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -69,000 | -36,000 | 232,000 | 204,000 | 188,000 |
| PPE Investments | -248,000 | -109,000 | -728,000 | -547,000 | -390,000 |
| Net Acquisitions | -794,000 | -551,000 | -1,797,000 | -1,579,000 | -1,131,000 |
| Purchase Of Investment | -192,000 | -125,000 | -172,000 | -166,000 | -44,000 |
| Other Investing Activity | -6,000 | -5,000 | -1,000 | -3,000 | -1,000 |
| Investing Cash Flow | $-1,309,000 | $-826,000 | $-2,466,000 | $-2,091,000 | $-1,378,000 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -1,500,000 | -1,500,000 | -500,000 |
| Common Stock Issued | 123,000 | 97,000 | 309,000 | 133,000 | 97,000 |
| Common Stock Repurchased | -550,000 | -400,000 | -1,396,000 | -604,000 | -424,000 |
| Dividend Paid | -1,913,000 | -969,000 | -3,709,000 | -2,794,000 | -1,865,000 |
| Other Financing Activity | -167,000 | -134,000 | -173,000 | -150,000 | -105,000 |
| Financing Cash Flow | $-2,507,000 | $-1,406,000 | $-6,469,000 | $-4,915,000 | $-2,797,000 |
| Exchange Rate Effect | 26,000 | 13,000 | -63,000 | -138,000 | -66,000 |
| Beginning Cash Position | 5,412,000 | 5,412,000 | 5,338,000 | 5,338,000 | 5,338,000 |
| End Cash Position | 5,704,000 | 4,936,000 | 5,412,000 | 4,699,000 | 4,739,000 |
| Net Cash Flow | $292,000 | $-476,000 | $74,000 | $-639,000 | $-599,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 4,082,000 | 1,744,000 | 9,072,000 | 6,505,000 | 3,642,000 |
| Capital Expenditure | -248,000 | -109,000 | -728,000 | -547,000 | -390,000 |
| Free Cash Flow | 3,834,000 | 1,635,000 | 8,344,000 | 5,958,000 | 3,252,000 |